April 23, 2025
HepQuant Celebrates Lab Week 2025!
Our amazing lab team is the backbone of our company, powering innovation, precision, and progress every single day. Their dedication to science, quality, and patient impact makes everything we do possible. This week, we recognize and thank our lab professionals for their hard work behind the scenes—advancing liver disease diagnostics and helping improve lives. 🔬 Here’s to the problem solvers, data champions, and science heroes in the lab. We appreciate you today and every day!
Endpoint NewsMay 22, 2023
“As it awaits key readout, Hepion boosts confidence in NASH drug hopeful via shorter study”
Press Releases
March 17, 2025
HepQuant to Present at Key Liver Conferences to Highlight Applications of HepQuant DuO™ – a Quantitative Liver Health Test
Recent clinical data demonstrates how HepQuant DuO test results may be used to inform endoscopy screening decisions, monitor disease progression and evaluate response to resmetirom therapy in patients with compensated advanced chronic liver disease (cACLD). Denver, CO – March 17, 2025 – HepQuant, LLC continues to expand clinical availability of…
Events
April 24, 2025 - April 25, 2025Orlando, FL
NAMCP’s Spring Managed Care Forum
HepQuant’s Paige Nardi (VP, Market Access, Billing & Reimbursement) and Kerry Whitaker (Senior Medical Science Liaison) will be attending NAMCP’s Spring Managed Care Forum on April 24–25 at Rosen Creek, Orlando, FL. Stop by Booth 216 to meet with them!
Amsterdam, the Netherlands | May 7 - 10, 2025
EASL Congress 2025
HepQuant’s own Dr. Gregory T. Everson, CEO will present two posters at EASL Congress 2025 in Amsterdam, the Netherlands May 7 – 10. Top Poster #507 “Quantifying liver function by cholate clearance in extracorporeal circuits with a genetically modified porcine liver and brain-dead human decedent” and poster #355 “The HepQuant…
San Diego, CA | May 3 -6, 2025
DDW 2025
Dr. Gregory T. Everson, CEO and founder of HepQuant, will discuss  “Simultaneous Quantification of Native Human Liver and Porcine Liver Function in an Extracorporeal Circuit Using IV 13C-Cholate.” at the upcoming DDW 2025 Late-Breaking Plenary session on May 3, 2025. Please join him in Room 25 from 2:00 to 3:00 pm…